This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Jun 15;359(9323):2048-50.

doi: 10.1016/S0140-6736(02)08946-8.

Therapeutic angiogenesis: a step forward in intermittent claudication

Richard Donnelly¹, Justin M C Yeung

Affiliations

PMID: 12086754
DOI: 10.1016/S0140-6736(02)08946-8

Comment

Therapeutic angiogenesis: a step forward in intermittent claudication

Richard Donnelly et al. Lancet. 2002.

. 2002 Jun 15;359(9323):2048-50.

doi: 10.1016/S0140-6736(02)08946-8.

Authors

Richard Donnelly¹, Justin M C Yeung

Affiliation

¹ School of Medical and Surgical Sciences, University of Nottingham, UK. Richard.donnelly@nottingham.ac.uk

PMID: 12086754
DOI: 10.1016/S0140-6736(02)08946-8

No abstract available

PubMed Disclaimer

Comment on

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.
Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, Annex BH; TRAFFIC Investigators. Lederman RJ, et al. Lancet. 2002 Jun 15;359(9323):2053-8. doi: 10.1016/s0140-6736(02)08937-7. Lancet. 2002. PMID: 12086757 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science